Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

S Mitragotri, PA Burke, R Langer - Nature reviews Drug discovery, 2014 - nature.com
The formulation and delivery of biopharmaceutical drugs, such as monoclonal antibodies
and recombinant proteins, poses substantial challenges owing to their large size and …

Pharmapolymers in the 21st century: Synthetic polymers in drug delivery applications

C Englert, JC Brendel, TC Majdanski, T Yildirim… - Progress in Polymer …, 2018 - Elsevier
The administration of drugs, as a main challenge of pharmaceutical and medicinal
applications, has certainly benefited from the application of synthetic polymers. However …

The chemistry of poly (2-oxazoline) s

B Verbraeken, BD Monnery, K Lava… - European Polymer …, 2017 - Elsevier
As we celebrate the 50th birthday of the discovery of poly (2-alkyl/aryl-2-oxazoline) s (PAOx)
this year we see a research field that is rapidly expanding after some lesser academic …

Poly (2‐oxazoline) s: A comprehensive overview of polymer structures and their physical properties

M Glassner, M Vergaelen… - Polymer …, 2018 - Wiley Online Library
Abstract Poly (2‐oxazoline) s (PAOx) are of increasing importance for a wide range of
applications, mostly in the biomedical field. This review describes the synthesis of 2 …

Poly (2‐oxazoline) s as Polymer Therapeutics

R Luxenhofer, Y Han, A Schulz, J Tong… - Macromolecular …, 2012 - Wiley Online Library
Abstract Poly (2‐oxazoline) s (POx) are currently discussed as an upcoming polymer
platform for biomaterials design and especially for polymer therapeutics. POx meet specific …

Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure–property relationships to better defined therapeutics

M Barz, R Luxenhofer, R Zentel, MJ Vicent - Polymer Chemistry, 2011 - pubs.rsc.org
Synthetic methods in polymer chemistry have evolved tremendously during the last decade.
Nowadays more and more attention is devoted to the application of those tools in the …

Poly (2‐Oxazoline) s–Are They More Advantageous for Biomedical Applications Than Other Polymers?

O Sedlacek, BD Monnery, SK Filippov… - Macromolecular …, 2012 - Wiley Online Library
Abstract Poly (2‐alkyl‐2‐oxazoline) s are biocompatible polymers with polypeptide‐isomeric
structures that are attracting increasing interest as biomaterials for drug, gene, protein, and …

Poly (2-oxazoline) s as materials for biomedical applications

VR de la Rosa - Journal of Materials Science: Materials in Medicine, 2014 - Springer
The conjunction of polymers and medicine enables the development of new materials that
display novel features, opening new ways to administrate drugs, design implants and …

Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents

F Jia, X Liu, L Li, S Mallapragada, B Narasimhan… - Journal of Controlled …, 2013 - Elsevier
Nanoparticles (NPs) have been extensively investigated for applications in both
experimental and clinical settings to improve delivery efficiency of therapeutic and …

Protein–polymer conjugation—moving beyond PEGylation

Y Qi, A Chilkoti - Current opinion in chemical biology, 2015 - Elsevier
Highlights•Limitations of conjugating poly (ethylene glycol) to proteins and peptides have
become increasingly apparent.•Various polymers have shown promise as PEG …